Novo Nordisk Increases Bid for Metsera Against Pfizer

Reported about 8 hours ago

Novo Nordisk is intensifying its efforts to outbid Pfizer for the development-stage drugmaker Metsera.

You may also interested in these wikis

Nvidia's Valuation Could Soar to $8.5 Trillion Amid AI Boom, Analyst Predicts

Beta Technologies' Successful NYSE Debut and $1 Billion Fundraising

Nintendo Shares Surge After Positive Switch 2 Outlook

New US-China Trade Deal: Key Updates on Tariffs and Rare Earth Exports

Meta Faces Challenges with AI Product Development

China Blames Netherlands for Semiconductor Supply Chain Crisis

S&P 500 Update: Amazon Rises After OpenAI Deal; Kimberly-Clark Acquires Kenvue

Low-Income Americans Sue Trump Officials for Food Assistance Funding

IBM Plans Job Cuts to Focus on Software Expansion

Kimberly-Clark Acquires Tylenol Maker Kenvue for $48.7 Billion

Back to all Wikis